SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-19-000805
Filing Date
2019-05-10
Accepted
2019-05-09 19:33:04
Documents
75
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q embi_10q.htm 10-Q 482770
2 EX-3.1 embi_ex31.htm EX-3.1 8557
3 CERTIFICATION embi_ex311.htm EX-31.1 8130
4 CERTIFICATION embi_ex312.htm EX-31.2 8288
5 CERTIFICATION embi_ex321.htm EX-32.1 3113
6 CERTIFICATION embi_ex322.htm EX-32.2 3121
13 embi_ex31img1.jpg GRAPHIC 399461
14 embi_ex31img10.jpg GRAPHIC 255670
15 embi_ex31img11.jpg GRAPHIC 318582
16 embi_ex31img12.jpg GRAPHIC 411558
17 embi_ex31img13.jpg GRAPHIC 464171
18 embi_ex31img14.jpg GRAPHIC 464567
19 embi_ex31img15.jpg GRAPHIC 456472
20 embi_ex31img2.jpg GRAPHIC 505998
21 embi_ex31img3.jpg GRAPHIC 455127
22 embi_ex31img4.jpg GRAPHIC 380189
23 embi_ex31img5.jpg GRAPHIC 441650
24 embi_ex31img6.jpg GRAPHIC 513959
25 embi_ex31img7.jpg GRAPHIC 419887
26 embi_ex31img8.jpg GRAPHIC 340835
27 embi_ex31img9.jpg GRAPHIC 256060
  Complete submission text file 0001640334-19-000805.txt   12578885

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT embi-20190331.xml EX-101.INS 830068
8 XBRL TAXONOMY EXTENSION SCHEMA embi-20190331.xsd EX-101.SCH 58102
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20190331_cal.xml EX-101.CAL 24855
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20190331_def.xml EX-101.DEF 266198
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20190331_lab.xml EX-101.LAB 421397
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20190331_pre.xml EX-101.PRE 343041
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 19812414
SIC: 2834 Pharmaceutical Preparations